WEAT news

Hedgeye Fourth Turning

Stories about this fund's companies, ranked by fund weight and recency. Times are local.

Quartz · 28 Oct 2026, 16:16 UTC
Best-selling drugs 2026: 7 of the top 10 by 2025 sales
2.4% of WEAT
Quartz · 28 Oct 2026, 14:15 UTC
New weight-loss drugs: what 6 drugmakers are testing
2.4% of WEAT
24/7 Wall St. · 28 Oct 2026, 19:24 UTC
16% of Employers Are Thinking About Cutting Weight-Loss Drug Coverage
1.4% of WEAT
www.theepochtimes.com · 28 Oct 2026, 00:00 UTC
Judge Declines to Block Eli Lilly Weight-Loss Drug Ads in Dispute With Novo Nordisk
2.4% of WEAT
Where to buy WEAT
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
Seeking Alpha · 28 Oct 2026, 15:55 UTC
Pharma giants Merck, Eli Lilly face earnings health check (MRK:NYSE) | Seeking Alpha
1.4% of WEAT
Seeking Alpha · 27 Oct 2026, 22:08 UTC
Novo Nordisk Vs. Eli Lilly Q3 Preview: I'd (Now) Buy Both, But Lilly Is My Top Pick (NVO) | Seeking Alpha
2.4% of WEAT
Where to buy WEAT
- [Broker A]Visit ↗
- [Broker B]Visit ↗
[Affiliate and risk wording from the law firm]
Benzinga · 28 Oct 2026, 13:25 UTC
Eli Lilly Says Retatrutide Delivers More Than Double Ozempic's Weight Loss in Late-Stage Diabetes Trial -
1.4% of WEAT
24/7 Wall St. · 28 Oct 2026, 12:14 UTC
3 Big Pharma Earnings Reports to Watch: Eli Lilly, Merck and Gilead
1.4% of WEAT
Market Screener · 28 Oct 2026, 12:07 UTC
Eli Lilly And Company Announces Positive Topline Results From TRANSCEND-T2D-2 Phase 3 Trial Of Retatrutide In Adults With Type 2 Diabetes
1.4% of WEAT
Fortune · 28 Oct 2026, 19:11 UTC
FTC and 20 states sue Dollar General, saying it overcharged its poorest customers by millions | Fortune
1.1% of WEAT
Benzinga · 28 Oct 2026, 10:04 UTC
Top Wall Street Forecasters Revamp Eli Lilly Expectations Ahead Of Q3 Earnings - Eli Lilly (NYSE:LLY)
1.4% of WEAT
wallstreet:online · 28 Oct 2026, 20:35 UTC
Food & Beverage Manufacturers Race to Scale AI Beyond the Pilot Stage
1.0% of WEAT
Yahoo! Finance · 28 Oct 2026, 07:29 UTC
The Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVie
1.4% of WEAT
The Guardian · 28 Oct 2026, 15:20 UTC
US lawmakers demand action on overcharging at 7-Eleven, Dollar General and other chains
1.1% of WEAT
TheStreet · 28 Oct 2026, 15:17 UTC
Dollar General asserts 20-state FTC lawsuit it's facing is a farce
1.1% of WEAT
The New York Times · 28 Oct 2026, 15:12 UTC
FTC Sues Dollar General Amid Growing Consumer Doubts Over Pricing
1.1% of WEAT
Quartz · 27 Oct 2026, 11:29 UTC
Judge rejects Novo Nordisk bid to block Eli Lilly weight-loss ads
2.4% of WEAT
Benzinga · 27 Oct 2026, 10:51 UTC
Novo Nordisk Loses Court Bid Against Eli Lilly's Weight-Loss Drug Ads -- Judge Says Sales Impact Was Negli
2.4% of WEAT
Quartz · 28 Oct 2026, 17:20 UTC
Lilly's retatrutide more than doubled Ozempic weight loss in trial
0.9% of WEAT
Benzinga · 28 Oct 2026, 11:07 UTC
DG Stock Declines Pre-Market as Dollar General Rejects FTC Allegations - Dollar General (NYSE:DG)
1.1% of WEAT